Cibc U.S. High Dividend Covered Call ETF (TSX:CUDC.F)
19.46
+0.07 (0.36%)
At close: Jun 5, 2026
-3.04% (1Y)
| Assets | 2.37M |
| Expense Ratio | n/a |
| PE Ratio | n/a |
| Dividend (ttm) | 1.24 |
| Dividend Yield | 6.37% |
| Ex-Dividend Date | Jun 30, 2026 |
| Payout Frequency | Monthly |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 153 |
| Open | 19.46 |
| Previous Close | 19.39 |
| Day's Range | 19.46 - 19.46 |
| 52-Week Low | 18.94 |
| 52-Week High | 20.67 |
| Beta | n/a |
| Holdings | 56 |
| Inception Date | Aug 25, 2025 |
About CUDC.F
CUDC.F.TO was created on 2025-08-25 by CIBC. The fund's investment portfolio concentrates primarily on high dividend yield equity. The fund invests in income-producing US companies while employing a covered call strategy to manage risk.
Asset Class Equity
Category High Dividend Yield
Stock Exchange Toronto Stock Exchange
Ticker Symbol CUDC.F
Provider CIBC
Top 10 Holdings
46.43% of assets| Name | Symbol | Weight |
|---|---|---|
| Microsoft Corporation | MSFT | 6.62% |
| Eli Lilly and Company | LLY | 5.85% |
| Apple Inc. | AAPL | 4.68% |
| NextEra Energy, Inc. | NEE | 4.51% |
| AbbVie Inc. | ABBV | 4.42% |
| Elevance Health, Inc. | ELV | 4.23% |
| JPMorgan Chase & Co. | JPM | 4.20% |
| Abbott Laboratories | ABT | 4.04% |
| AstraZeneca PLC | AZN | 3.96% |
| L3Harris Technologies, Inc. | LHX | 3.90% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 30, 2026 | 0.120 CAD | Jul 6, 2026 |
| May 29, 2026 | 0.120 CAD | Jun 3, 2026 |
| Apr 30, 2026 | 0.125 CAD | May 5, 2026 |
| Mar 31, 2026 | 0.125 CAD | Apr 6, 2026 |
| Feb 27, 2026 | 0.125 CAD | Mar 4, 2026 |
| Jan 30, 2026 | 0.125 CAD | Feb 4, 2026 |